Targeting BCL-2 regulated apoptosis in cancerKirsteen J. Campbell, Stephen W. G. Tait|Open Biology|2018Cited by 538
MCL-1 is a prognostic indicator and drug target in breast cancerKirsteen J. Campbell, Karen Blyth|Cell Death and Disease|2018Cited by 202
Breast cancer dependence on MCL-1 is due to its canonical anti-apoptotic functionKirsteen J. Campbell, Stephen W. G. Tait, Catherine Cloix et al.|Cell Death and Differentiation|2021Cited by 49
CITED2 coordinates key hematopoietic regulatory pathways to maintain the HSC pool in both steady-state hematopoiesis and transplantationHannah Lawson, Kamil R. Kranc, Louie N. van de Lagemaat et al.|Stem Cell Reports|2021Cited by 19